Robert Fox, MD

Appointed
2002

Education & Fellowships

Graduate School - Case Western Reserve University School of Medicine
Cleveland, OH
2003

Fellowship - Cleveland Clinic
Neuroimmunology
Cleveland, OH
2002

Residency - Hospital of The University of Pennsylvania
Neurology
Philadelphia, PA
2000

Internship - Hospital of The University of Pennsylvania
Medicine
Philadelphia, PA
1997

Medical Education - Johns Hopkins University School of Medicine
Baltimore, MD
1996

Undergraduate - Amherst College
Amherst, MA
1991

Additional Training

• Masters of Science in Clinical Research, Case Western Reserve University, 2003

Professional Highlights

• Advisory Committee on Fellowships, National Multiple Sclerosis Society (Chair, 2011-2012)
• International Coordinating Investigator, Phase III clinical trial of BG00012
• Editorial Board, Neurology and Multiple Sclerosis Journal
• Managing Director, NARCOMS MS Patient Registry
• Scientific Expert Working Group on CCSVI, Canadian Institutes of Health Research
• MS Clinical Phenotype Subcommittee, International Advisory Committee on Clinical Trials in MS
• Medical Monitor, Phase I Study of Mesenchymal Stem Cell Transplantation in MS
• Ad hoc reviewer, NIH ZRG1 BDCN-N Member Conflict Special Emphasis Panel
• Committee for Responsible Research Conduct, Cleveland Clinic
• Neurosciences Sub-Chair, Research Programs Committee, Cleveland Clinic

Certifications

• Psychiatry and Neurology - Neurology

Specialty Interests

Multiple Sclerosis, Neuroimmunology

Awards & Honors

• 1991    James Olds Memorial Neuroscience Thesis Award
• 1992    Alpha Omega Alpha Honor Society Grant
• 1996    Sellards Travel Award to Johannesburg, South Africa
• 1996    Medical and Chirurgical Society of Maryland Award for Excellence in Organized Medicine
• 1996    Harold Lamport Biomedical Research Prize, Johns Hopkins University
• 1999    Zeritzky Resident Clinical Research Award, University of Pennsylvania
• 2000    Potiker Fellow, Mellen Center for Multiple Sclerosis Treatment and Research
• 2001    National Multiple Sclerosis Society Dale McFarlin Travel Award
• 2003-2012    Top Doctors, Cleveland Magazine
• 2008    Outstanding Physician/PA Team, Cleveland Clinic
• 2009    Fellow, American Academy of Neurology
• 2011    Researcher Hall of Fame, National MS Society

Memberships

• American Academy of Neurology
• American Society of Neuroimaging
• American Medical Association

See publications for Robert Fox, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 8/30/2024, Dr. Fox has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Fox receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Kiniksa Pharmaceuticals Corp.
• Viracta Therapeutics, Inc.
• Immunic, Inc.
• Novartis International, AG
• Sanofi Genzyme
• Biogen Idec, Inc.
• TG Therapeutics, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.